Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers

A structural look at α-synuclein oligomers Fibrillar aggregates of the protein α-synuclein (αS) are the major constituents of Lewy bodies in Parkinson's disease. However, small oligomers that accumulate during the process of fibril formation are thought to cause the neuronal toxicity associated with the onset and progression of Parkinson's disease. Little is known about the detailed structural properties of αS oligomers and the molecular mechanisms that lead to their toxicity. Fusco et al. report the structural characterization of two forms of αS oligomers, which elucidates the fundamental structural elements giving rise to neuronal toxicity. Science, this issue p. 1440 Oligomers of α-synuclein generate neuronal damage when insertion of a highly structured core disrupts membrane integrity. Oligomeric species populated during the aggregation process of α-synuclein have been linked to neuronal impairment in Parkinson’s disease and related neurodegenerative disorders. By using solution and solid-state nuclear magnetic resonance techniques in conjunction with other structural methods, we identified the fundamental characteristics that enable toxic α-synuclein oligomers to perturb biological membranes and disrupt cellular function; these include a highly lipophilic element that promotes strong membrane interactions and a structured region that inserts into lipid bilayers and disrupts their integrity. In support of these conclusions, mutations that target the region that promotes strong membrane interactions by α-synuclein oligomers suppressed their toxicity in neuroblastoma cells and primary cortical neurons.

[1]  C. Dobson,et al.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.

[2]  C. Dobson,et al.  Inhibition of α-Synuclein Fibril Elongation by Hsp70 Is Governed by a Kinetic Binding Competition between α-Synuclein Species. , 2017, Biochemistry.

[3]  C. Dobson,et al.  Structural basis of synaptic vesicle assembly promoted by α-synuclein , 2016, Nature Communications.

[4]  C. Dobson,et al.  Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases , 2016, Scientific Reports.

[5]  C. Dobson,et al.  Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity , 2016, Scientific Reports.

[6]  C. Dobson,et al.  Ca2+ is a key factor in α-synuclein-induced neurotoxicity , 2016, Journal of Cell Science.

[7]  Charles D. Schwieters,et al.  Solid-State NMR Structure of a Pathogenic Fibril of Full-Length Human α-Synuclein , 2016, Nature Structural &Molecular Biology.

[8]  Michael J. Devine,et al.  Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease , 2016, Antioxidants & redox signaling.

[9]  Nicholas K. Sauter,et al.  Structure of the toxic core of α-synuclein from invisible crystals , 2015, Nature.

[10]  C. Dobson,et al.  Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation , 2015, Proceedings of the National Academy of Sciences.

[11]  D. Selkoe,et al.  Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction* , 2014, The Journal of Biological Chemistry.

[12]  Michele Vendruscolo,et al.  Direct Observation of the Three Regions in α-Synuclein that Determine its Membrane-Bound Behaviour , 2014, Nature Communications.

[13]  D. Otzen,et al.  The N‐terminus of α‐synuclein is essential for both monomeric and oligomeric interactions with membranes , 2014, FEBS letters.

[14]  F. Chiti,et al.  TDP-43 Inclusion Bodies Formed in Bacteria Are Structurally Amorphous, Non-Amyloid and Inherently Toxic to Neuroblastoma Cells , 2014, PloS one.

[15]  B. Meier,et al.  Structural and functional characterization of two alpha-synuclein strains , 2013, Nature Communications.

[16]  F. Chiti,et al.  Extracellular chaperones prevent Aβ42-induced toxicity in rat brains. , 2013, Biochimica et biophysica acta.

[17]  E. Masliah,et al.  The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.

[18]  Christopher M. Dobson,et al.  Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.

[19]  L. Kay,et al.  Studying "invisible" excited protein states in slow exchange with a major state conformation. , 2012, Journal of the American Chemical Society.

[20]  C. Rienstra,et al.  Structural intermediates during α-synuclein fibrillogenesis on phospholipid vesicles. , 2012, Journal of the American Chemical Society.

[21]  F. Chiti,et al.  A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells , 2011, Journal of cellular and molecular medicine.

[22]  Nicolas L. Fawzi,et al.  Atomic resolution dynamics on the surface of amyloid β protofibrils probed by solution NMR , 2011, Nature.

[23]  Patrick A. Lewis,et al.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.

[24]  Fred H. Gage,et al.  In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.

[25]  A. Fersht,et al.  Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53 , 2010, Nucleic acids research.

[26]  P. Brundin,et al.  Membrane interaction of α-synuclein in different aggregation states. , 2012, Journal of Parkinson's disease.

[27]  C. Burd,et al.  Aggregation of α-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis , 2011, Journal of Molecular Neuroscience.

[28]  Michael A. Geeves,et al.  Targeted Amino-Terminal Acetylation of Recombinant Proteins in E. coli , 2010, PloS one.

[29]  S. Lindquist,et al.  α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.

[30]  Fabrizio Chiti,et al.  A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.

[31]  Vladimir N Uversky,et al.  Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. , 2009, Current protein & peptide science.

[32]  Ad Bax,et al.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. , 2009, Journal of molecular biology.

[33]  P. Lansbury,et al.  The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast. , 2009, Journal of molecular biology.

[34]  Henning Stahlberg,et al.  The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.

[35]  D. Ehrnhoefer,et al.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.

[36]  G. Melacini,et al.  Analysis and optimization of saturation transfer difference NMR experiments designed to map early self-association events in amyloidogenic peptides. , 2008, The journal of physical chemistry. B.

[37]  R. Leurs,et al.  The Akt/GSK‐3β axis as a new signaling pathway of the histamine H3 receptor , 2007 .

[38]  Armin Giese,et al.  Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding , 2007, The Journal of Neuroscience.

[39]  G. Melacini,et al.  Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. , 2007, Journal of the American Chemical Society.

[40]  Armin Giese,et al.  Different species of alpha-synuclein oligomers induce calcium influx and seeding. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  G. Melacini,et al.  Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. , 2007, Journal of the American Chemical Society.

[42]  R. Leurs,et al.  The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor. , 2007, Journal of neurochemistry.

[43]  R. Muhandiram,et al.  The molecular interaction of human salivary histatins with polyphenolic compounds. , 2001, European journal of biochemistry.

[44]  K. Takegoshi,et al.  13C-1H dipolar recoupling under very fast magic-angle spinning using virtual pulses. , 1999, Solid State Nuclear Magnetic Resonance.

[45]  Gareth A. Morris,et al.  Enhancement of nuclear magnetic resonance signals by polarization transfer , 1979 .

[46]  E. Elson,et al.  Fluorescence correlation spectroscopy. I. Conceptual basis and theory , 1974 .